Companies
/Financial Services
Hyperliquid Strategies Inc Common Stock
$12.85
▼ $1.24 (−8.80%) today
Markets closed · 2:36pm ET
Fundamentals
Market Cap
$2.5B
P/E Ratio
4.0
Profit Margin
3,230.0%
Revenue (TTM)
$9.5M
EPS (TTM)
$3.21
52-Week Range
$3 – $15
Street Target
$22.32
About PURR
Hyperliquid Strategies Inc., through its subsidiary, is a a biotechnology company that owns a platform for biologic medicines of single or bifunctional action. The company is headquartered in New York, New York.